CartiHeal

OverviewSuggest Edit

CartiHeal is a medical device company. It offers implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints.
TypePrivate
Founded2009
HQKefar Sava, IL
Websitecartiheal.com

Latest Updates

Employees (est.) (Dec 2021)25
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at CartiHeal

Nir Altschuler

Nir Altschuler

CEO & Founder

CartiHeal Office Locations

CartiHeal has an office in Kefar Sava
Kefar Sava, IL (HQ)
Atir Yeda St 17, Kefar Sava
Show all (1)

CartiHeal Financials and Metrics

Summary Metrics

Founding Date

2009

CartiHeal total Funding

$50.8 m

CartiHeal latest funding size

$15 m

Time since last funding

2 years ago

CartiHeal investors

CartiHeal's latest funding round in July 2020 was reported to be $15 m. In total, CartiHeal has raised $50.8 m
Show all financial metrics

CartiHeal Online and Social Media Presence

Embed Graph

CartiHeal News and Updates

Bioventus Proceeds with Option Structure Agreement with CartiHeal

DURHAM, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has elected to make a $50 million escrow payment pursuant to its Option and Equity Purchase Agreement with CartiHeal Ltd., signaling its i…

CartiHeal Receives FDA "Breakthrough Device Designation" for the novel Agili-C Implant

KFAR SABA, Israel, Oct. 12, 2020 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today that FDA has granted Breakthrough Device Designation for the Agili-C implant™. FDA's...

CartiHeal Raises $15M in Equity Funding from Bioventus

CartiHeal, the Kfar Saba, Israel-based developer of the proprietary Agili™-C implant for the treatment of joint surface lesions in traumatic and osteoarthritic joints, secured an additional $15m equity investment from Bioventus, a global leader in orthobiologics. The investment follows the recently …

CartiHeal Blogs

CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects

Four patients enrolled and operated on by sports medicine surgeon Dr. Seth L. Sherman, MD The post CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects appeared first on The Future of join…

Joint Surface Lesions in the Knee Treated with an Acellular Aragonite-Based Scaffold: A 3-Year Follow-Up Case Series

Wouter Van Genechten1,2 , Kristien Vuylsteke1, Caroline Struijk2, Linus Swinnen3 , and Peter Verdonk1,2,4 Abstract Objective. The study aimed to evaluate the clinical outcome and repair capacity of a cell-free aragonite-based scaffold in patients with an isolated symptomatic joint surface lesion (J…

CartiHeal Receives FDA “Breakthrough Device Designation” for the novel Agili-C Implant

Four patients enrolled and operated on by sports medicine surgeon Dr. Seth L. Sherman, MD The post CartiHeal Receives FDA “Breakthrough Device Designation” for the novel Agili-C Implant appeared first on The Future of joint Repair.

CartiHeal Frequently Asked Questions

  • When was CartiHeal founded?

    CartiHeal was founded in 2009.

  • Who are CartiHeal key executives?

    CartiHeal's key executives are Nir Altschuler.

  • How many employees does CartiHeal have?

    CartiHeal has 25 employees.

  • Who are CartiHeal competitors?

    Competitors of CartiHeal include Nidhi Meditech Systems, Protego Medical and Structure Medical.

  • Where is CartiHeal headquarters?

    CartiHeal headquarters is located at Atir Yeda St 17, Kefar Sava, Kefar Sava.

  • Where are CartiHeal offices?

    CartiHeal has an office in Kefar Sava.

  • How many offices does CartiHeal have?

    CartiHeal has 1 office.